Endothelin-induced contraction of the portal vein in cirrhosis

European Surgical Research

Volumn 31, Issue 3, 1999, Pages 289-296

  Petrowsky, H ^a   Schmandra, Th ^a   Lorey, Th ^a   Hanisch, E ^a   Herrmann, G ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Endothelin; Liver cirrhosis; Portal hypertension; Portal vein; Vasoconstriction

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; HUMAN; LIVER CIRRHOSIS; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PRIORITY JOURNAL; RAT; STELLATE CELL; VASOCONSTRICTION;

EID: 0033011103     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008705     Document Type: Article

References (47)

1. Yanagisawa M, Kurikava H, Kiunara S, Tomobe Y, Kobayasi M, Mitui Y, Yazaki Y, Goto M, Masaki T: Endothelin: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415.
2. Takahashi K, Jones PM, Kause SM, Lam HC, Spokes RA, Ghatei MA, Bloom SR: Endothelin in the gastrointestinal tract. Gastroenterology 1990;99:1660-1667.
3. Matsumoto H, Suzuki N, Onda H, Fujino M: Abundance of endothelin-3 in rat intestine, pituitary gland and brain. Biochem Biophys Res Commun 1989;164:74-80.
4. Pinzani M,Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, Tosti-Guerra C, Maggi M, Failli P, Ruocco C, Gentilini P: Endothelin-1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996;110: 534-548.
5. Shichiri M, Hirata Y, Emori T, Ohta K, Nakajima T, Sato K, Sato A, Marumo F: Secretion of endothelin and related peptides from renal epithelial cell lines. FEBS Lett 1989;253: 203-206.
6. Black PN, Ghatei MA, Takahashi K, Bretherton-Watt D, Krausz T, Dollery CT, Bloom SR: Formation of endothelin by cultured airway epithelial cells. FEBS Lett 1989;255: 129-132.
7. Lee M, de la Monte S, Ng S, Bloch KD, Quertermous T: Expression of the potent vasoconstrictor endothelin in the human central nervous system. J Clin Invest 1990;86:141-147.
8. Xuan Y-T, Whorton AR, Shearer-Poor E, Boyd J, Watkins WD: Determination of immuno-reactive endothelin in medium from cultured endothelial cells and human plasma. Biochem Biophys Res Commun 1989;164:326-332.
9. Uchihera M, Izumi N, Sato C, Marumo F: Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology 1992;16:95-99.
10. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K: Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 1992;327: 1774-1778.
11. Gerbes AL, Maller S, Gulberg V, Henriksen JH: Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: Role of splanchnic and renal passage and liver function. Hepatology 1995;21:735-739.
12. Isobe H, Satoh M, Sakai H, Nawata H: Increased plasma endothelin-1 levels in patients with cirrhosis and esophageal varices. J Clin Gastroenterol 1993;17:227-230.
13. Møller S, Gulberg V, Henriksen JH, Gerbes AL: Endothelin-1 and endothelin-3 in cirrhosis: Relation to systemic and splanchnic haemodynamics. J Hepatol 1995;23:135-144.
14. Tomita K, Ujie K, Nakanishi T, Tomura S, Matsuda O, Ando K, Shichiri M, Hirata Y, Marumo F: Plasma endothelin levels in patients with acute renal failure. N Engl J Med 1989;321:1127.
15. Totsune K, Mouri T, Takakashi K, Ohneda M, Sone M, Saito T, Yoshinaga K: Detection of immunoreactive endothelin in plasma of hemodialysis patients. FEBS Lett 1989; 249:239-242.
16. Rodeheffer RJ, Cerman A, Heublein DM, Burnett JC: Increased plasma concentration of endothelin in congestive heart failure in humans. Mayo Clin Proc 1992;67:719-724.
17. Salminen K, Tikkanen I, Saijonmaa O, Nieminen M, Fyhrquist F, Frick MH: Modulation of coronary tone in acute myocardial infarction by endothelin. Lancet 1989;23:747.
18. Saito Y, Nakao K, Mukoyama M, Imura H: Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990; 322:205.
19. Gandhi CR, Stephenson K, Olson MS: Endothelin, a potent peptide agonist in the liver. J Biol Chem 1990;265:17432-17435.
20. Okumura S, Takei Y, Kawano S, Nagano K, Masudo E, Goto M, Tsuji S, Michida T, Chen S, Kashiwagi T, Fusamoto H, Kamada T, Sato N: Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology 1994; 19:155-161.
21. Elliot AJ, Vo LT, Grossman VL, Bhathal PS, Grossman HJ: Endothelin-induced vasocontraction in isolated perfused liver preparations from normal and cirrhotic rats. J Gastroenterol Hepatol 1977;12: 314-318.
22. Rockey D: The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin and nitric oxide. Hepatology 1997;25:2-5.
23. Rockey DC, Weisiger R: Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: Implication for regulation of portal pressure and resistance. Hepatology 1996;24:233-240.
24. Proctor E, Chatamra K: High yield micronodular cirrhosis in the rat. Gastroenterology 1982;83:1183-1190.
25. Franklin KJ: The circulation in the mesenteric vein of the sheep. J Physiol (Lond) 1925;59:74-75P.
26. Maloff GA: Zur Pharmakologie der Venen. Über selbständige Venenkontraktionen. Arch Int Pharmacodyn 1934;48:333-353.
27. Funaki S, Bohr DF: Electrical and mechanical activity of isolated vascular muscle of the rat. Nature 1964; 203:192-194.
28. Hellstrand P, Järhult J: Effect of nine different gastrointestinal polypeptides on vascular smooth muscle in vitro. Acta Physiol Scand 1980; 110:89-94.
29. Hanisch E, Strasse R, Wenzel M, Lorey T: In vitro-Kontraktilitätsverhalten der Pfortader gesunder und lebercirrhotischer Ratten - Einfluss von Kalziumantagonisten und Octreotide. Z Gastroenterol 1993;31: 600-604.
30. Sutter MC: The pharmacology of isolated veins. Br J Pharmacol 1965; 24:742-751.
31. Ts'ao CH, Glagov S, Kelsey BF: Special strucural features of the rat portal vein. Anat Rec 1970;166: 529-540.
32. ++ on force-velocity characteristics of normal and hypertrophic smooth muscle of the rat portal vein. Acta Physiol Scand 1985;124:525-533.
33. Kaumann AJ, Groszmann RJ: Catecholamines relax portal and mesenteric veins from normal and portal hypertensive rats. Am J Physiol 1989;257:G977-G981.
34. Reilly WM, Burnstock G: The effect of ATP analogues on the spontaneous electrical and mechanical activity of rat portal vein longitudinal muscle. Eur J Pharmacol 1987;138: 319-325.
35. 1-adrenoceptor sub-types in the phasic and tonic responses to phenylephrine in the longitudinal smooth muscle of the rat portal vein. Naunyn-Schmiedebergs Arch Pharmacol 1991;343:463-471.
36. Gonda K, Ueno T, Sakamoto M, Sakisaka S, Sata M, Tanikawa K: The endothelin-1 binding site in rat liver tissue: Light- and electron-microscopic autoradiographic studies. Gastroenterology 1993;104:1745-1749.
37. Clozel M, Gray GA, Breu V, Loffler BM, Osterwalder R: The endothelin ETB receptor mediates both vasodilatation and vasoconstriction in vivo. Biochem Biophys Res Commun 1992;186:867-873.
38. Sakurai T, Yanagisawa M, Masaki T: Molecular characterization of endothelin receptors. Trends Pharmacol Sci 1992;13:103-108.
39. Arner M, Högestätt ED: Endothelin-dependent relaxation and effects of prostacyclin, endothelin and platelet-activating factor in human hand veins and arteries. Acta Physiol Scand 1991;142:165-172.
40. Moreno L, Martinez-Cuesta MA, Pique JM, Bosch J, Esplugues JV: Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 1996;354:474-480.
41. Sugiura M, Inagami T, Kon V: Endotoxin stimulates endothelin release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989; 161:1220-1222.
42. Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Buhler FR: Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: A novel autocrine function. Cell Regul 1990;9:649-659.
43. Hartleb M, Moreau R, Cailmail S, Gaudin C, Lebrec D: Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis. Gastroenterology 1994;197:1085-1093.
44. Leivas A, Jiménez W, Lamas S, Bosch-Marcé, Oriola J, Clària J, Arroyo V, Rivera F, Rodés J: Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites. Gastroenterology 1995;108:1842-1848.
45. Yamamoto S, Burman HP, O'Donnell CP, Cahill PA, Robotham JL: Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock. Am J Physiol 1997;272:H1239-1249.
46. Yu PC, Juo JS, Lin HC, Yang CM: Effects of endothelin in portal hypertensive rats. Clin Sci 1992;83: 165-170.
47. Hodges R, Zhang S, Cahill PA, Redmond RA, Sitzmann JV: Vascular hyperresponsiveness to endothelin in the hyperemic vasculature of portal hypertensive rats (abstract). Gastroenterology 1995;108:A1223.